Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Farmers Insurance
Chubb
Queensland Health
Argus Health
AstraZeneca
Johnson and Johnson
Express Scripts
Baxter

Generated: August 18, 2018

DrugPatentWatch Database Preview

Chlorpheniramine maleate; codeine phosphate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for chlorpheniramine maleate; codeine phosphate and what is the scope of chlorpheniramine maleate; codeine phosphate patent protection?

Chlorpheniramine maleate; codeine phosphate is the generic ingredient in one branded drug marketed by Spriaso Llc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorpheniramine maleate; codeine phosphate has fifty-eight patent family members in eleven countries.

There are twenty-nine drug master file entries for chlorpheniramine maleate; codeine phosphate. One supplier is listed for this compound.

Summary for chlorpheniramine maleate; codeine phosphate
Pharmacology for chlorpheniramine maleate; codeine phosphate

US Patents and Regulatory Information for chlorpheniramine maleate; codeine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Spriaso Llc TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Spriaso Llc TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Spriaso Llc TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for chlorpheniramine maleate; codeine phosphate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,015,224,130 ➤ Sign Up
6,267,985 Clear oil-containing pharmaceutical compositions ➤ Sign Up
6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Fuji
Medtronic
Argus Health
Mallinckrodt
Colorcon
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.